Doer Biologics begins patient dosing in phase 2 study of DR10624 to treat metabolic dysfunction-associated steatotic liver disease and MASH: Hangzhou, China Thursday, April 24, 20 ...

This discovery is important because it reveals a hidden layer of how pancreatic cancer resists treatment. If Galectin-1 ...

An Austrian study has shown that injection of autologous myoblasts and fibroblasts is much more effective than collagen injection for the treatment of urinary stress incontinence. The randomized ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ...

Quick advancements in cancer treatment are crucial as traditional therapies face challenges of limited specificity and ...

Hyperbaric oxygen therapy (HBOT ) is a promising treatment for non-healing wounds, offering hope for patients who have not responded to conventional therapies. This treatment involves patients ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Please provide your email address to receive an email when new articles are posted on . A master cell bank has been completed for a product that will utilize fibroblasts to treat chronic wounds.

New research demonstrates the role of the Galectin-1 protein in the nucleus of the cells surrounding the tumor-fibroblasts ...

Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ...

For more information, please visit FibroBiologics' website or email FibroBiologics at: [email protected].